World CRISPR Day brings together the entire genome engineering community to discuss how we can safely enable discovery, therapeutics, and practical applications.
This unique digital event features an incredible cast of talented genome engineers, scientists, and key opinion leaders. They’ll engage the research community with insights, practical methods to apply in the lab, and a vision for the future of CRISPR.
CRISPR pioneer and 2020 Nobel Laureate Dr. Jennifer Doudna will open the symposium with her keynote address before attendees hear from expert speakers from across many application areas of CRISPR, followed by a panel featuring producers and scientists from the Human Nature documentary.
Join us at World CRISPR Day to hear academic and industry experts talk about their transformative research, visit our partner’s booths, take advantage of the different networking sessions with your peers, and much more!
University of California, Berkeley, biochemist Jennifer Doudna, also the scientific advisor of SYNTHEGO, won the 2020 Nobel Prize in Chemistry, sharing it with colleague Emmanuelle Charpentier for the co-development of CRISPR-Cas9, a genome editing breakthrough that has revolutionized biomedicine.
First proposed as a gene-editing tool by Doudna and her team in 2012, CRISPR now serves as the foundation for modern genome engineering and is considered one of the most exciting scientific advancements in history. Using CRISPR, researchers can precisely edit DNA to eradicate diseases and solve some of society’s biggest challenges.
“Synthego is one of the most promising and necessary companies to emerge in the field of genome engineering,” said Jennifer Doudna. “By increasing access to this scientific advancement, Synthego will have an immediate impact on life sciences researchers and is poised to transform the industry by making the application of CRISPR simpler, faster, and more valuable to innovators previously unable to realize its full potential.”
The efficiency and agility of Synthego’s technology has positioned the company as one of the world’s leading authorities on CRISPR. Synthego’s full-stack genome engineering platform expedites research processes and allows scientists to study the fundamentals of biology, develop novel therapeutics for human disease, advance agriculture, and produce sustainable energy and chemicals. Most importantly, Synthego’s CRISPR offering is easily incorporated into existing workflows, enabling rapid and cost-effective research with consistent, accurate results for every scientist.
“As one of the foremost leaders of genome engineering, Jennifer will greatly enhance our efforts in bringing biology as a service to life sciences,” said Paul Dabrowski, Chief Executive Officer of Synthego. “We are establishing the concept of, and setting the standards for, agile biopharma by bringing engineering principles to the field of biology.
You’ve heard of CRISPR, now learn how it works.
Impress colleagues with up-to-date knowledge.
Build the foundation to using CRISPR yourself.